Annual Drug Patent Expirations for ERLEADA
Erleada is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are eleven patents protecting this drug.
Drug patent litigation for ERLEADA.
This drug has two hundred and thirty-three patent family members in forty-six countries.
The generic ingredient in ERLEADA is apalutamide. One supplier is listed for this compound. Additional details are available on the apalutamide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
